$12.47 Billion in Sales Expected for HCA Healthcare Inc (NYSE:HCA) This Quarter

Equities research analysts expect that HCA Healthcare Inc (NYSE:HCA) will announce $12.47 billion in sales for the current fiscal quarter, according to Zacks. Nine analysts have issued estimates for HCA Healthcare’s earnings, with the highest sales estimate coming in at $13.44 billion and the lowest estimate coming in at $10.88 billion. HCA Healthcare posted sales of $12.69 billion during the same quarter last year, which would indicate a negative year-over-year growth rate of 1.7%. The company is scheduled to issue its next earnings results on Tuesday, November 3rd.

On average, analysts expect that HCA Healthcare will report full-year sales of $49.81 billion for the current year, with estimates ranging from $46.25 billion to $51.60 billion. For the next year, analysts anticipate that the business will post sales of $54.07 billion, with estimates ranging from $51.37 billion to $56.10 billion. Zacks’ sales averages are an average based on a survey of research firms that cover HCA Healthcare.

HCA Healthcare (NYSE:HCA) last released its earnings results on Wednesday, July 22nd. The company reported $3.23 EPS for the quarter, beating analysts’ consensus estimates of ($0.94) by $4.17. HCA Healthcare had a negative return on equity of 589.47% and a net margin of 6.67%. The firm had revenue of $11.07 billion for the quarter, compared to analysts’ expectations of $10.44 billion. During the same quarter in the prior year, the firm posted $2.21 earnings per share. The company’s quarterly revenue was down 12.2% on a year-over-year basis.

HCA has been the topic of several research analyst reports. Truist increased their price objective on HCA Healthcare from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Wednesday, September 16th. UBS Group dropped their price objective on HCA Healthcare from $138.00 to $137.00 and set a “buy” rating on the stock in a research note on Thursday, June 11th. BMO Capital Markets cut HCA Healthcare from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock from $121.00 to $100.00 in a research note on Monday, July 13th. Zacks Investment Research upgraded HCA Healthcare from a “hold” rating to a “buy” rating and set a $132.00 target price for the company in a report on Tuesday, September 22nd. Finally, SunTrust Banks upped their target price on HCA Healthcare from $130.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, July 23rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and sixteen have given a buy rating to the company’s stock. HCA Healthcare has an average rating of “Buy” and an average price target of $148.89.

NYSE:HCA traded down $0.12 during midday trading on Monday, hitting $124.56. The stock had a trading volume of 1,845,666 shares, compared to its average volume of 2,469,063. HCA Healthcare has a one year low of $58.38 and a one year high of $151.97. The company has a market capitalization of $42.11 billion, a price-to-earnings ratio of 12.84, a PEG ratio of 1.22 and a beta of 1.40. The stock has a 50-day moving average of $131.85 and a 200 day moving average of $111.28. The company has a quick ratio of 0.95, a current ratio of 1.09 and a debt-to-equity ratio of 54.19.

In other news, insider A Bruce Moore, Jr. sold 15,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $133.73, for a total transaction of $2,005,950.00. Following the completion of the sale, the insider now owns 88,626 shares in the company, valued at approximately $11,851,954.98. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP P. Martin Paslick sold 227 shares of the stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $134.97, for a total value of $30,638.19. Following the sale, the senior vice president now owns 2,621 shares of the company’s stock, valued at approximately $353,756.37. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,481 shares of company stock valued at $2,070,363. Company insiders own 1.80% of the company’s stock.

A number of hedge funds have recently modified their holdings of HCA. Public Employees Retirement Association of Colorado raised its stake in HCA Healthcare by 3.2% in the 1st quarter. Public Employees Retirement Association of Colorado now owns 50,903 shares of the company’s stock worth $4,574,000 after acquiring an additional 1,602 shares during the last quarter. WINTON GROUP Ltd acquired a new stake in HCA Healthcare during the 1st quarter worth about $1,217,000. Rockefeller Capital Management L.P. grew its position in HCA Healthcare by 67.0% during the 1st quarter. Rockefeller Capital Management L.P. now owns 1,919 shares of the company’s stock worth $172,000 after purchasing an additional 770 shares during the period. Principal Financial Group Inc. grew its position in HCA Healthcare by 8.9% during the 1st quarter. Principal Financial Group Inc. now owns 1,627,629 shares of the company’s stock worth $146,243,000 after purchasing an additional 132,811 shares during the period. Finally, Sontag Advisory LLC acquired a new stake in HCA Healthcare during the 1st quarter worth about $273,000. Institutional investors own 68.28% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: Forex

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.